LEAH BENNETT: Open Payments
NPI 1902332760 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 64 payments from 11 companies in 2025. Trend: 2023 $1,159 · 2024 $1,710 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $303 |
| Lilly USA, LLC | 5 | $187 |
| Amgen Inc. | 11 | $185 |
| UCB, Inc. | 7 | $128 |
| Regeneron Healthcare Solutions, Inc. | 6 | $113 |
| Janssen Biotech, Inc. | 4 | $86 |
| GENZYME CORPORATION | 3 | $55 |
| LEO Pharma Inc. | 2 | $49 |
| Organon LLC | 3 | $44 |
| PFIZER INC. | 2 | $34 |
Products named: SKYRIZI, Otezla, DUPIXENT, EBGLYSS, Bimzelx, TREMFYA, ADBRY, RINVOQ.
Industry payments across SD — which companies pay providers there.
